NCT04008524 2025-08-06
A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies
Institute of Hematology & Blood Diseases Hospital, China
Available
Institute of Hematology & Blood Diseases Hospital, China
University of California, San Francisco
Northwell Health